title: The cost effectiveness of cardiovascular medicines.
authors.affiliation: Department of Pharmaceutical Economics and Policy, University of Southern California, Center for the Health Professions CHP-140, 1540 E. Alcazar Street, Los Angeles, CA 90089, USA. JHay@usc.edu
authors.forename: Joel
authors.initials: J
authors.lastname: Hay
mesh_terms: D002317:Cardiovascular Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005102:Health Expenditures; D006801:Humans; D014481:United States
chemical_list: D002317:Cardiovascular Agents
references.citation: BMJ. 2003 Jun 28;326(7404):1419
references.pmid: 12829553
references.citation: Milbank Q. 1998;76(4):517-63, 509
references.pmid: 9879302
references.citation: Curr Control Trials Cardiovasc Med. 2004 Jun 4;5(1):4
references.pmid: 15180910
references.citation: Am Heart J. 2000 Jan;139(1 Pt 1):106-13
references.pmid: 10618570
references.citation: Am J Manag Care. 2003 Jun;9 Spec No 1:SP13-24
references.pmid: 12817612
references.citation: BMJ. 1998 Sep 12;317(7160):720-6
references.pmid: 9732339
references.citation: Health Aff (Millwood). 2004 Jan-Feb;23(1):147-59
references.pmid: 15002637